_id
6910970bccc777a4e85d5b95
Ticker
ENGN
Name
enGene Holdings Inc. Common Stock
Exchange
NASDAQ
Address
4868 Rue Levy, Montreal, QC, Canada, H4R 2P1
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.engene.com
Description
enGene Holdings Inc., through its subsidiary enGene, Inc., operates as a clinical-stage biotechnology company in Canada. The company develops genetic medicines to help patients suffering from bladder cancer. Its lead product candidate is detalimogene voraplasmid, a monotherapy for the treatment of non-muscle invasive bladder cancer (NMIBC). Its pipeline includes LEGEND, which is in Phase 2. enGene Holdings Inc. is based in Montreal, Canada.
Last Close
9.09
Volume
127274
Current Price
8.71
Change
-0.18
Last Updated
2026-01-03T11:01:01.193Z
Image
data:image/webp;base64,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
Ipo Date
2023-11-01T00:00:00.000Z
Market Cap
604871488
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.984
Sentiment Sources
1
Rating
4.3
Target Price
23.5
Strong Buy
4
Buy
5
Hold
1
Sell
0
Strong Sell
0
Current Quarter
2025-10-31
Revenue
0
Cost Of Revenue
171000
Gross Profit
-171000
Operating Expenses
39310000
Operating Income
-39481000
Interest Expense
750000
Pretax Income
-38377000
Net Income
-37880000
Eps
-0.7383342026497388
Dividends Per Share
-
Shares Outstanding
66984661
Income Tax Expense
-497000
EBITDA
-37456000
Operating Margin
-
Total Other Income Expense Net
1104000
Cash
50152000
Short Term Investments
143663000
Receivables
2227000
Inventories
-
Total Current Assets
201391000
Property Plant Equipment
10193000
Total Assets
221468000
Payables
6688000
Short Term Debt
10016000
Long Term Debt
15324000
Total Liabilities
53758000
Equity
167710000
Bs_currency_symbol
USD
Depreciation
171000
Change In Working Capital
10126000
Cash From Operations
-24962000
Capital Expenditures
437000
Cash From Investing
40500000
Cash From Financing
1991000
Net Change In Cash
17529000
Cf_currency_symbol
USD
PE
-
PB
2.6645027893387394
ROE
-22.586607834953192
ROA
-17.104051149601748
FCF
-25399000
Fcf Percent
-
Piotroski FScore
1
Health Score
43
Deep Value Investing Score
3
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
2
Growth Investing Score
0.5
Momentum Investing Score
2.5
Net Net Investing Score
1
Quality Investing Score
2.5
Value Investing Score
4
Quarters > 0 > quarter
2025-10-31
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
171000
Quarters > 0 > income Statement > gross Profit
-171000
Quarters > 0 > income Statement > operating Expenses
39310000
Quarters > 0 > income Statement > operating Income
-39481000
Quarters > 0 > income Statement > interest Expense
750000
Quarters > 0 > income Statement > pretax Income
-38377000
Quarters > 0 > income Statement > net Income
-37880000
Quarters > 0 > income Statement > eps
-0.7383342026497388
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
51304680
Quarters > 0 > income Statement > income Tax Expense
-497000
Quarters > 0 > income Statement > EBITDA
-37456000
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
1104000
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
50152000
Quarters > 0 > balance Sheet > short Term Investments
143663000
Quarters > 0 > balance Sheet > receivables
2227000
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
201391000
Quarters > 0 > balance Sheet > property Plant Equipment
10193000
Quarters > 0 > balance Sheet > total Assets
221468000
Quarters > 0 > balance Sheet > payables
6688000
Quarters > 0 > balance Sheet > short Term Debt
10016000
Quarters > 0 > balance Sheet > long Term Debt
15324000
Quarters > 0 > balance Sheet > total Liabilities
53758000
Quarters > 0 > balance Sheet > equity
167710000
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-37880000
Quarters > 0 > cash Flow > depreciation
171000
Quarters > 0 > cash Flow > change In Working Capital
10126000
Quarters > 0 > cash Flow > cash From Operations
-24962000
Quarters > 0 > cash Flow > capital Expenditures
437000
Quarters > 0 > cash Flow > cash From Investing
40500000
Quarters > 0 > cash Flow > cash From Financing
1991000
Quarters > 0 > cash Flow > net Change In Cash
17529000
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-0.7383342026497388
Quarters > 0 > ratios > PB
2.6645027893387394
Quarters > 0 > ratios > ROE
-22.586607834953192
Quarters > 0 > ratios > ROA
-17.104051149601748
Quarters > 0 > ratios > FCF
-25399000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
43
Quarters > 1 > quarter
2025-07-31
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
130000
Quarters > 1 > income Statement > gross Profit
-130000
Quarters > 1 > income Statement > operating Expenses
29947000
Quarters > 1 > income Statement > operating Income
29947000
Quarters > 1 > income Statement > interest Expense
758000
Quarters > 1 > income Statement > pretax Income
28752000
Quarters > 1 > income Statement > net Income
-28991000
Quarters > 1 > income Statement > eps
-0.5673639666559623
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
51097711
Quarters > 1 > income Statement > income Tax Expense
239000
Quarters > 1 > income Statement > EBITDA
-27864000
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
-1195000
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
32622999
Quarters > 1 > balance Sheet > short Term Investments
169362000
Quarters > 1 > balance Sheet > receivables
709000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
211312000
Quarters > 1 > balance Sheet > property Plant Equipment
9848000
Quarters > 1 > balance Sheet > total Assets
245550000
Quarters > 1 > balance Sheet > payables
2384000
Quarters > 1 > balance Sheet > short Term Debt
6939000
Quarters > 1 > balance Sheet > long Term Debt
17706000
Quarters > 1 > balance Sheet > total Liabilities
44878000
Quarters > 1 > balance Sheet > equity
200672000
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-28991000
Quarters > 1 > cash Flow > depreciation
-2071000
Quarters > 1 > cash Flow > change In Working Capital
1066000
Quarters > 1 > cash Flow > cash From Operations
-25634000
Quarters > 1 > cash Flow > capital Expenditures
704000
Quarters > 1 > cash Flow > cash From Investing
1379000
Quarters > 1 > cash Flow > cash From Financing
-667000
Quarters > 1 > cash Flow > net Change In Cash
-24922000
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-0.5673639666559623
Quarters > 1 > ratios > PB
2.2178533268717113
Quarters > 1 > ratios > ROE
-14.446958220379525
Quarters > 1 > ratios > ROA
-11.806556709427815
Quarters > 1 > ratios > FCF
-26338000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
43
Quarters > 2 > quarter
2025-04-30
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
106000
Quarters > 2 > income Statement > gross Profit
-106000
Quarters > 2 > income Statement > operating Expenses
27124000
Quarters > 2 > income Statement > operating Income
27124000
Quarters > 2 > income Statement > interest Expense
734000
Quarters > 2 > income Statement > pretax Income
25575000
Quarters > 2 > income Statement > net Income
25815000
Quarters > 2 > income Statement > eps
0.5059879652678414
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
51019000
Quarters > 2 > income Statement > income Tax Expense
240000
Quarters > 2 > income Statement > EBITDA
-24735000
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
-1549000
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
57545000
Quarters > 2 > balance Sheet > short Term Investments
159919000
Quarters > 2 > balance Sheet > receivables
533000
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
227974000
Quarters > 2 > balance Sheet > property Plant Equipment
3193000
Quarters > 2 > balance Sheet > total Assets
266651000
Quarters > 2 > balance Sheet > payables
1567000
Quarters > 2 > balance Sheet > short Term Debt
4001000
Quarters > 2 > balance Sheet > long Term Debt
20023000
Quarters > 2 > balance Sheet > total Liabilities
39360000
Quarters > 2 > balance Sheet > equity
227291000
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-25815000
Quarters > 2 > cash Flow > depreciation
-1297000
Quarters > 2 > cash Flow > change In Working Capital
1149000
Quarters > 2 > cash Flow > cash From Operations
-22947000
Quarters > 2 > cash Flow > capital Expenditures
45000
Quarters > 2 > cash Flow > cash From Investing
17947000
Quarters > 2 > cash Flow > cash From Financing
199000
Quarters > 2 > cash Flow > net Change In Cash
-4801000
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
0.5059879652678414
Quarters > 2 > ratios > PB
1.9550949663647046
Quarters > 2 > ratios > ROE
11.357686841977905
Quarters > 2 > ratios > ROA
9.681193770133996
Quarters > 2 > ratios > FCF
-22992000
Quarters > 2 > ratios > Piotroski FScore
2
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
75
Quarters > 3 > quarter
2025-01-31
Quarters > 3 > income Statement > revenue
0
Quarters > 3 > income Statement > cost Of Revenue
102000
Quarters > 3 > income Statement > gross Profit
-102000
Quarters > 3 > income Statement > operating Expenses
26613000
Quarters > 3 > income Statement > operating Income
-26613000
Quarters > 3 > income Statement > interest Expense
752000
Quarters > 3 > income Statement > pretax Income
-24598000
Quarters > 3 > income Statement > net Income
-24616000
Quarters > 3 > income Statement > eps
-0.4828844380799184
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
50977000
Quarters > 3 > income Statement > income Tax Expense
18000
Quarters > 3 > income Statement > EBITDA
-23744000
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
2015000
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
62346000
Quarters > 3 > balance Sheet > short Term Investments
151542000
Quarters > 3 > balance Sheet > receivables
430000
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
222320000
Quarters > 3 > balance Sheet > property Plant Equipment
3057000
Quarters > 3 > balance Sheet > total Assets
285932000
Quarters > 3 > balance Sheet > payables
2605000
Quarters > 3 > balance Sheet > short Term Debt
2106000
Quarters > 3 > balance Sheet > long Term Debt
21696000
Quarters > 3 > balance Sheet > total Liabilities
35982000
Quarters > 3 > balance Sheet > equity
249950000
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-24616000
Quarters > 3 > cash Flow > depreciation
102000
Quarters > 3 > cash Flow > change In Working Capital
-2601000
Quarters > 3 > cash Flow > cash From Operations
-25696000
Quarters > 3 > cash Flow > capital Expenditures
299000
Quarters > 3 > cash Flow > cash From Investing
-84964000
Quarters > 3 > cash Flow > cash From Financing
1000
Quarters > 3 > cash Flow > net Change In Cash
-110658000
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-0.4828844380799184
Quarters > 3 > ratios > PB
1.7763939587917585
Quarters > 3 > ratios > ROE
-9.848369673934787
Quarters > 3 > ratios > ROA
-8.60903991158737
Quarters > 3 > ratios > FCF
-25995000
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
42
Annuals > 0 > quarter
2025-10-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
509000
Annuals > 0 > income Statement > gross Profit
-509000
Annuals > 0 > income Statement > operating Expenses
123165000
Annuals > 0 > income Statement > operating Income
-123165000
Annuals > 0 > income Statement > interest Expense
2994000
Annuals > 0 > income Statement > pretax Income
-117302000
Annuals > 0 > income Statement > net Income
117302000
Annuals > 0 > income Statement > eps
2.2946634491325706
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
51119479
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-113799000
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
5863000
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
50152000
Annuals > 0 > balance Sheet > short Term Investments
143663000
Annuals > 0 > balance Sheet > receivables
2227000
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
201391000
Annuals > 0 > balance Sheet > property Plant Equipment
10193000
Annuals > 0 > balance Sheet > total Assets
221468000
Annuals > 0 > balance Sheet > payables
6688000
Annuals > 0 > balance Sheet > short Term Debt
10016000
Annuals > 0 > balance Sheet > long Term Debt
15324000
Annuals > 0 > balance Sheet > total Liabilities
53758000
Annuals > 0 > balance Sheet > equity
167710000
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-117302000
Annuals > 0 > cash Flow > depreciation
-2558000
Annuals > 0 > cash Flow > change In Working Capital
9740000
Annuals > 0 > cash Flow > cash From Operations
-99239000
Annuals > 0 > cash Flow > capital Expenditures
1485000
Annuals > 0 > cash Flow > cash From Investing
-25138000
Annuals > 0 > cash Flow > cash From Financing
1524000
Annuals > 0 > cash Flow > net Change In Cash
-122852000
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
2.2946634491325706
Annuals > 0 > ratios > PB
2.697557624172679
Annuals > 0 > ratios > ROE
69.94335460020274
Annuals > 0 > ratios > ROA
52.965665468600434
Annuals > 0 > ratios > FCF
-100724000
Annuals > 0 > ratios > Piotroski FScore
2
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
74
Annuals > 1 > quarter
2024-10-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
323000
Annuals > 1 > income Statement > gross Profit
-323000
Annuals > 1 > income Statement > operating Expenses
61974000
Annuals > 1 > income Statement > operating Income
62297000
Annuals > 1 > income Statement > interest Expense
2798000
Annuals > 1 > income Statement > pretax Income
55161000
Annuals > 1 > income Statement > net Income
-55142000
Annuals > 1 > income Statement > eps
-1.2353152022940095
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
44638000
Annuals > 1 > income Statement > income Tax Expense
-19000
Annuals > 1 > income Statement > EBITDA
-52040000
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
-7136000
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
173004000
Annuals > 1 > balance Sheet > short Term Investments
65400000
Annuals > 1 > balance Sheet > receivables
1032000
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
247362000
Annuals > 1 > balance Sheet > property Plant Equipment
2910000
Annuals > 1 > balance Sheet > total Assets
311173000
Annuals > 1 > balance Sheet > payables
1411000
Annuals > 1 > balance Sheet > short Term Debt
1122000
Annuals > 1 > balance Sheet > long Term Debt
22473000
Annuals > 1 > balance Sheet > total Liabilities
38561000
Annuals > 1 > balance Sheet > equity
272612000
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-55142000
Annuals > 1 > cash Flow > depreciation
91000
Annuals > 1 > cash Flow > change In Working Capital
95000
Annuals > 1 > cash Flow > cash From Operations
-48281000
Annuals > 1 > cash Flow > capital Expenditures
925000
Annuals > 1 > cash Flow > cash From Investing
-125953000
Annuals > 1 > cash Flow > cash From Financing
265716000
Annuals > 1 > cash Flow > net Change In Cash
91483000
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-1.2353152022940095
Annuals > 1 > ratios > PB
1.4491155928572477
Annuals > 1 > ratios > ROE
-20.22728273150118
Annuals > 1 > ratios > ROA
-17.720689134340063
Annuals > 1 > ratios > FCF
-49206000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
34
Annuals > 2 > quarter
2023-10-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
175000
Annuals > 2 > income Statement > gross Profit
-175000
Annuals > 2 > income Statement > operating Expenses
25885000
Annuals > 2 > income Statement > operating Income
-26060000
Annuals > 2 > income Statement > interest Expense
4953000
Annuals > 2 > income Statement > pretax Income
-99900000
Annuals > 2 > income Statement > net Income
-99917000
Annuals > 2 > income Statement > eps
-4.24149934202148
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
23557000
Annuals > 2 > income Statement > income Tax Expense
17000
Annuals > 2 > income Statement > EBITDA
-94772000
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
-73840000
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
81521000
Annuals > 2 > balance Sheet > short Term Investments
76000
Annuals > 2 > balance Sheet > receivables
2343000
Annuals > 2 > balance Sheet > inventories
76000
Annuals > 2 > balance Sheet > total Current Assets
85440000
Annuals > 2 > balance Sheet > property Plant Equipment
589000
Annuals > 2 > balance Sheet > total Assets
86959000
Annuals > 2 > balance Sheet > payables
1156000
Annuals > 2 > balance Sheet > short Term Debt
562000
Annuals > 2 > balance Sheet > long Term Debt
9216000
Annuals > 2 > balance Sheet > total Liabilities
14473000
Annuals > 2 > balance Sheet > equity
72486000
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-99917000
Annuals > 2 > cash Flow > depreciation
175000
Annuals > 2 > cash Flow > change In Working Capital
-517000
Annuals > 2 > cash Flow > cash From Operations
-24743000
Annuals > 2 > cash Flow > capital Expenditures
318000
Annuals > 2 > cash Flow > cash From Investing
-318000
Annuals > 2 > cash Flow > cash From Financing
86147000
Annuals > 2 > cash Flow > net Change In Cash
61087000
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-4.24149934202148
Annuals > 2 > ratios > PB
2.8761340120850925
Annuals > 2 > ratios > ROE
-137.84316971553127
Annuals > 2 > ratios > ROA
-114.90127531365356
Annuals > 2 > ratios > FCF
-25061000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
34
Annuals > 3 > quarter
2022-10-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
-
Annuals > 3 > income Statement > gross Profit
-
Annuals > 3 > income Statement > operating Expenses
19427000
Annuals > 3 > income Statement > operating Income
-1831421
Annuals > 3 > income Statement > interest Expense
1423000
Annuals > 3 > income Statement > pretax Income
30726
Annuals > 3 > income Statement > net Income
30726
Annuals > 3 > income Statement > eps
0.0019430848036425725
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
15813000
Annuals > 3 > income Statement > income Tax Expense
22000
Annuals > 3 > income Statement > EBITDA
268726
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
1862147
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
314151
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
1336000
Annuals > 3 > balance Sheet > inventories
74000
Annuals > 3 > balance Sheet > total Current Assets
511804
Annuals > 3 > balance Sheet > property Plant Equipment
387000
Annuals > 3 > balance Sheet > total Assets
132043138
Annuals > 3 > balance Sheet > payables
723000
Annuals > 3 > balance Sheet > short Term Debt
1265000
Annuals > 3 > balance Sheet > long Term Debt
30845000
Annuals > 3 > balance Sheet > total Liabilities
4621009
Annuals > 3 > balance Sheet > equity
127422129
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-24462000
Annuals > 3 > cash Flow > depreciation
238000
Annuals > 3 > cash Flow > change In Working Capital
2174000
Annuals > 3 > cash Flow > cash From Operations
-17592000
Annuals > 3 > cash Flow > capital Expenditures
153000
Annuals > 3 > cash Flow > cash From Investing
-153000
Annuals > 3 > cash Flow > cash From Financing
27967000
Annuals > 3 > cash Flow > net Change In Cash
9417000
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
0.0019430848036425725
Annuals > 3 > ratios > PB
1.0982790124311923
Annuals > 3 > ratios > ROE
0.024113550951577647
Annuals > 3 > ratios > ROA
0.023269668129213956
Annuals > 3 > ratios > FCF
-17745000
Annuals > 3 > ratios > Piotroski FScore
2
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
49
Valuation > metrics > PE
-0.7383342026497388
Valuation > metrics > PB
2.6645027893387394
Valuation > final Score
80
Valuation > verdict
Fair
Profitability > metrics > ROE
-22.586607834953192
Profitability > metrics > ROA
-18.80918213822862
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.3205414107685886
Risk > metrics > Interest Coverage
-52.641333333333336
Risk > final Score
-151
Risk > verdict
High
Liquidity > metrics > Current Ratio
12.056453544061302
Liquidity > metrics > Quick Ratio
12.056453544061302
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
80
Prev Valuations > 1
100
Prev Valuations > 2
80
Prev Profitabilities > 0
15
Prev Profitabilities > 1
68
Prev Profitabilities > 2
15
Prev Risks > 0
100
Prev Risks > 1
100
Prev Risks > 2
-82
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T21:46:49.159Z
Earnings History > 0 > period
2025-10-31
Earnings History > 0 > report Date
2025-12-22
Earnings History > 0 > date
2025-10-31
Earnings History > 0 > before After Market
AfterMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.73
Earnings History > 0 > eps Estimate
-0.58
Earnings History > 0 > eps Difference
-0.15
Earnings History > 0 > surprise Percent
-25.8621
Earnings History > 1 > period
2025-07-31
Earnings History > 1 > report Date
2025-09-11
Earnings History > 1 > date
2025-07-31
Earnings History > 1 > before After Market
AfterMarket
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.57
Earnings History > 1 > eps Estimate
-0.51
Earnings History > 1 > eps Difference
-0.06
Earnings History > 1 > surprise Percent
-11.7647
Earnings History > 2 > period
2025-04-30
Earnings History > 2 > report Date
2025-06-12
Earnings History > 2 > date
2025-04-30
Earnings History > 2 > before After Market
BeforeMarket
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.51
Earnings History > 2 > eps Estimate
-0.48
Earnings History > 2 > eps Difference
-0.03
Earnings History > 2 > surprise Percent
-6.25
Earnings History > 3 > period
2025-01-31
Earnings History > 3 > report Date
2025-03-10
Earnings History > 3 > date
2025-01-31
Earnings History > 3 > before After Market
AfterMarket
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.48
Earnings History > 3 > eps Estimate
-0.37
Earnings History > 3 > eps Difference
-0.11
Earnings History > 3 > surprise Percent
-29.7297
Earnings History > 4 > period
2024-10-31
Earnings History > 4 > report Date
2024-12-19
Earnings History > 4 > date
2024-10-31
Earnings History > 4 > before After Market
AfterMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.34
Earnings History > 4 > eps Estimate
-0.36
Earnings History > 4 > eps Difference
0.02
Earnings History > 4 > surprise Percent
5.5556
Earnings History > 5 > period
2024-07-31
Earnings History > 5 > report Date
2024-09-10
Earnings History > 5 > date
2024-07-31
Earnings History > 5 > before After Market
AfterMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.32
Earnings History > 5 > eps Estimate
-0.35
Earnings History > 5 > eps Difference
0.03
Earnings History > 5 > surprise Percent
8.5714
Earnings History > 6 > period
2024-04-30
Earnings History > 6 > report Date
2024-06-14
Earnings History > 6 > date
2024-04-30
Earnings History > 6 > before After Market
BeforeMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.38
Earnings History > 6 > eps Estimate
-0.27
Earnings History > 6 > eps Difference
-0.11
Earnings History > 6 > surprise Percent
-40.7407
Earnings History > 7 > period
2024-01-31
Earnings History > 7 > report Date
2024-03-11
Earnings History > 7 > date
2024-01-31
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.46
Earnings History > 7 > eps Estimate
-0.47
Earnings History > 7 > eps Difference
0.01
Earnings History > 7 > surprise Percent
2.1277
Earnings History > 8 > period
2023-10-31
Earnings History > 8 > report Date
2024-01-03
Earnings History > 8 > date
2023-10-31
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-4.5119
Earnings History > 8 > eps Estimate
-
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2023-07-31
Earnings History > 9 > report Date
2023-07-31
Earnings History > 9 > date
2023-07-31
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.0031
Earnings History > 9 > eps Estimate
-
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2023-04-30
Earnings History > 10 > report Date
2023-06-30
Earnings History > 10 > date
2023-04-30
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.1713
Earnings History > 10 > eps Estimate
-
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2023-01-31
Earnings History > 11 > report Date
2023-03-30
Earnings History > 11 > date
2023-01-31
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
0.04
Earnings History > 11 > eps Estimate
-
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2022-10-31
Earnings History > 12 > report Date
2022-11-10
Earnings History > 12 > date
2022-10-31
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
0.0392
Earnings History > 12 > eps Estimate
-
Earnings History > 12 > eps Difference
0
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2022-07-31
Earnings History > 13 > report Date
2022-08-11
Earnings History > 13 > date
2022-07-31
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.02
Earnings History > 13 > eps Estimate
-
Earnings History > 13 > eps Difference
0
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2022-04-30
Earnings History > 14 > report Date
2022-05-13
Earnings History > 14 > date
2022-04-30
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.03
Earnings History > 14 > eps Estimate
-
Earnings History > 14 > eps Difference
0
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2022-01-31
Earnings History > 15 > report Date
2022-04-14
Earnings History > 15 > date
2022-01-31
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.01
Earnings History > 15 > eps Estimate
-
Earnings History > 15 > eps Difference
0
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2021-10-31
Earnings History > 16 > report Date
2022-01-24
Earnings History > 16 > date
2021-10-31
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
-
Earnings History > 16 > eps Actual
0
Earnings History > 16 > eps Estimate
0
Earnings History > 16 > eps Difference
0
Earnings History > 16 > surprise Percent
-
enGene Holdings Inc., through its subsidiary enGene, Inc., operates as a clinical-stage biotechnology company in Canada. The company develops genetic medicines to help patients suffering from bladder cancer. Its lead product candidate is detalimogene voraplasmid, a monotherapy for the treatment of non-muscle invasive bladder cancer (NMIBC). Its pipeline includes LEGEND, which is in Phase 2. enGene Holdings Inc. is based in Montreal, Canada.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AenGene Holdings (NASDAQ: ENGN) adds $125M debt facility and new warrants Stock Titan
Read more →Showing 2 of 10
(Last Updated 2025-10-31)
Rating:
BUY
Target Price:
$23.5
Analyst Picks
Strong Buy
4
Buy
5
Hold
1
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-10-31)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of enGene Holdings Inc. Common Stock
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-10-31
EPS Actual
-0.73
EPS Estimate
-0.58
EPS Difference
-0.15
Surprise Percent
-25.8621%
(Last Updated 2025-10-31)
(Last Updated 2025-10-31)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-10-31)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-10-31)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.